Skip to content

Investigating the effect of physiotherapy on reducing ear pain

Investigating the effect of treating musculoskeletal disorders of the head and neck with a manual therapy techniques package on symptoms of secondary otalgia: A randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160221026674N8
Enrollment
32
Registered
2025-12-27
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary otalgia. Otalgia

Interventions

Intervention 1: In the intervention group, patients receive a manual therapy package session including dry needling of the head and neck muscles and cervical spine mobilization, along with 10 days of

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Presence of an earache Age between 25 and 60 years Presence of active trigger points in any of the masseter, temporalis, medial and lateral pterygoid, upper trapezius, sternocleidomastoid, and sub-occipital muscles Presence of dysfunction in any of the cervical vertebrae

Exclusion criteria

Exclusion criteria: Diagnosis of primary otalgia External and internal ear infections Earwax Ear inflammation Limitation of range of motion of the temporomandibular joint with the presence of sound and sensitivity to touch in this joint Cervical discopathy Spinal canal stenosis in the cervical region Primary headaches Systemic diseases and positive vertebro-basilar test Head and neck malignancy Oral and mucosal lesions Dental injuries (dental and gum infections, abnormal alignment or placement of teeth when the mouth is closed) Sinusitis and upper airway infections diagnosed by an ear specialist

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Participants were instructed to indicate their average pain intensity on a 0–10 numerical rating scale, where 0 represented “no pain” and 10 represented “the worst pain imaginable.”.

Secondary

MeasureTime frame
Pain frequency. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Number of days of pain in the past 10 days as reported by the patient.;Number of trigger points. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Presence of referred pain and a jump sign on manual examination.;Cervical range of motion. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Goniometry.;Mandibular depression range. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: Number of sticks placed in the mouth.;Quality of life. Timepoint: At baseline, post-treatment, and one-month follow-up. Method of measurement: SF-36 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Mohamadi

Shiraz University of Medical Science

mohamadm@sums.ac.ir+98 71 3212 2600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026